Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Applied Therapeutics
Biotech
Applied Tx’s pediatric rare disease prosect hits another snag
The FDA needs more time to review Applied's application for rare disease prospect govorestat, sending the biotech's stock tumbling after hours.
Gabrielle Masson
Mar 29, 2024 10:21am
Applied claims victory in phase 3 SORD fight, plots path to FDA
Feb 15, 2024 10:10am
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Applied Therapeutics fails heart disease phase 3, seeks partner
Jan 5, 2024 8:03am
Applied fails phase 3 trial, plans to seek approval anyway
Apr 24, 2023 9:10am
Applied pumps brakes on FDA application after request for data
Jan 4, 2022 3:30pm